| Literature DB >> 31163020 |
Luiz Thiberio Rangel1,2,3, Jeremiah Marden1, Sophie Colston1, João Carlos Setubal2,3, Joerg Graf1,4, Johann Peter Gogarten1,4.
Abstract
The genetic determinants of bacterial pathogenicity are highly variable between species and strains. However, a factor that is commonly associated with virulent Gram-negative bacteria, including many Aeromonas spp., is the type 3 secretion system (T3SS), which is used to inject effector proteins into target eukaryotic cells. In this study, we developed a bioinformatics pipeline to identify T3SS effector proteins, applied this approach to the genomes of 105 Aeromonas strains isolated from environmental, mutualistic, or pathogenic contexts and evaluated the cytotoxicity of the identified effectors through their heterologous expression in yeast. The developed pipeline uses a two-step approach, where candidate Aeromonas gene families are initially selected using Hidden Markov Model (HMM) profile searches against the Virulence Factors DataBase (VFDB), followed by strict comparisons against positive and negative control datasets, greatly reducing the number of false positives. This approach identified 21 Aeromonas T3SS likely effector families, of which 8 represent known or characterized effectors, while the remaining 13 have not previously been described in Aeromonas. We experimentally validated our in silico findings by assessing the cytotoxicity of representative effectors in Saccharomyces cerevisiae BY4741, with 15 out of 21 assayed proteins eliciting a cytotoxic effect in yeast. The results of this study demonstrate the utility of our approach, combining a novel in silico search method with in vivo experimental validation, and will be useful in future research aimed at identifying and authenticating bacterial effector proteins from other genera.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31163020 PMCID: PMC6548356 DOI: 10.1371/journal.pone.0214035
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Phylogeny of 105 Aeromonas spp. genomes.
Tree branches with sh-like aLRT support of at least 90% are highlighted with red circles. The binary heat map represents the presence/absence of T3SS apparatus and identified putative effectors in Aeromonas spp. isolates. The dark gray squares in the T3SS-1 column denote partial presence of the apparatus due to missing genes. The isolation source colors represent: green, veterinary; yellow, sick veterinary; blue, environment; orange, feces; red, blood; purple, wound; and pink, human.
Relevant characteristics of putative T3SS effector groups.
Number of proteins describes the total number of protein-encoding genes identified across all assayed genomes for a given group.
| Effector | # of proteins (# of T | Length in bp | Pfam domains | Domain descriptions | # of proteins with a type III secretion signal | GOterms |
|---|---|---|---|---|---|---|
| 1 (0–0) | 1383 | PF01734 | Patatin-like phospholipase | 1, 1 | lipid metabolic process | |
| 1 (0–0) | 1032 | N/A | N/A | 0, 1 | N/A | |
| 3 (2–0) | 1059, 969, 963 | PF03543 | Yersinia/Haemophilus virulence surface antigen | 2, 3 | cysteine-type endopeptidase activity, pathogenesis | |
| 7 (0–2.79) | 2010, 1872, 1833 | PF01734 | Patatin-like phospholipase | 5, 7 | lipid metabolic process | |
| 1 (0–0) | 1098 | PF03496 | ADP-ribosytransferase exoenzyme | 0, 1 | extracellular region, pathogenesis | |
| 2 (1–1) | 678, 615, 552 | PF03496 | ADP-ribosytransferase exoenzyme | 1, 2 | extracellular region, pathogenesis | |
| 51 (0–31.9) | 1443, 1128, 1083 | PF13776; PF02661 | Domain of unknown function (DUF4172); Fic/DOC family | 4, 1 | N/A | |
| 5 (0–1) | 1155, 1155, 1149 | PF02661 | Fic/DOC family | 0, 5 | N/A | |
| 20 (5–5) | 1429, 1353, 1287 | PF03496; PF03545 | ADP-ribosyltransferase exoenzyme; Yersinia virulence determinant (YopE) | 9, 17 | extracellular region, pathogenesis | |
| 6 (0–0) | 1488, 1488, 1242 | PF03372 | Endonuclease/Exonuclease/ phosphatase family | 6, 5 | N/A | |
| 6 (0–0) | 897 | PF03421 | YopJ Serine/Threonine acetyltransferase | 6, 5 | N/A | |
| 9 (0–3) | 1392, 1206, 1152 | PF00102; PF09013 | Protein-tyrosine phosphatase; YopH, N-terminal | 1, 9 | protein tyrosine phosphatase activity, protein dephosphorylation, protein tyrosine phosphatase activity, protein dephosphorylation, pathogenesis | |
| 5 (0–1) | 2188, 2187, 2187 | PF09632; PF00069 | Rac1-binding domain; Protein kinase domain | 5, 4 | protein kinase activity, ATP binding, protein phosphorylation | |
| 4 (0–2) | 1089, 1083, 1083 | N/A | N/A | 0, 4 | N/A | |
| 5 (0–2) | 1044, 1044, 999 | N/A | N/A | 5, 5 | N/A | |
| 1 (0–0) | 708 | PF03536 | Salmonella virulence-associated 28kDa protein | 1, 1 | N/A | |
| 3 (2–2) | 1452, 1452, 1446 | N/A | N/A | 3, 3 | N/A | |
| 2 (1–1) | 1134, 1132.5, 1131 | PF03497 | Anthrax toxin LF subunit | 0, 1 | GO:0005576, GO:0008294, pathogenesis | |
| 11 (0–4.86) | 1422 | PF09013 | YopH, N-terminal | 11, 11 | GO:0004725, GO:0006470, pathogenesis | |
| 27 (0–13.5) | 2112, 2103, 1944 | N/A | N/A | 20, 27 | N/A | |
| 36 (14–14) | 972, 951, 948 | N/A | N/A | 36, 35 | N/A | |
| 30 (4–18) | 951, 903, 492 | N/A | N/A | 15, 28 | N/A | |
| 42 (15–15) | 1545, 1537.5, 768 | PF03545 | Yersinia virulence determinant (YopE) | 24, 41 | N/A |
$: Duplication, transfer, and loss events were estimated using Ranger-DTL [58] (see the Materials and Methods for additional details). No duplication was predicted within the putative effectors assayed. The number of transfers (T) with 100% confidence and the mean number of transfer events is given in parentheses, respectively.
$$: In instances where the max, median and min nucleotide length of genes was identical, a single value is given.
$$$: Domains present in an effector group were identified using the Pfam database, and the PFAM associated Go terms are given.
$$$$: Obtained using EffectiveT3 2.0.1 and Bean 2.0, respectively.
Fig 2Yeast growth inhibition assay.
Strains carrying putative T3SS effectors cloned into pGREG533 were cultured overnight in SDM-His-Glu, washed and 10-fold serially diluted. Aliquots from each dilution (10 μl) were spotted onto SDM-His-Glu and SDM-His-Gal plates. A strain containing pGREG533 was used as a negative control and showed no growth inhibition. SDM-His-Glu and SDM-His-Gal plates were incubated at 30°C for 2–3 days. T3SS effectors previously identified or biochemically characterized are presented in panel (A), whereas those identified in the present study are shown in panel (B).
Fig 3Yeast growth inhibition assay under stress conditions.
Strains carrying putative T3SS effectors cloned into pGREG533 were grown overnight in SDM-His-Glu, washed and 10-fold serially diluted. Aliquots from each dilution (10 μl) were spotted onto SDM-His-Glu or on SDM-His-Gal plates containing either 0.5 M NaCl or 7 mM caffeine. The strain containing pGREG533 was used as a negative control and showed no growth inhibition. The plates were incubated at 30°C for 2–3 days.